Skip to content
2000
Volume 25, Issue 9
  • ISSN: 1566-5240
  • E-ISSN: 1875-5666

Abstract

Purpose

To investigate the effect of the SUMOylation inhibitor TAK981 on hydrogen peroxide (HO)-induced oxidative damage in human retinal pigment epithelial cells (ARPE-19) and its regulatory mechanism.

Methods

An oxidative damage model of ARPE-19 cells induced by HO was established, and 1, 2, and 5 μM TAK981 solutions were administered for intervention respectively. Normal cells were used as the control group. The viability of the cells in each group was detected by the methyl thiazolyl tetrazolium (MTT) method. The levels of superoxide dismutase (SOD) and malondialdehyde (MDA) in each group of cells were detected by biochemical methods. The levels of IL-1β and TNF-α produced by each group of cells were detected by enzyme-linked immunosorbent assay (ELISA). The protein expression levels of Nrf2, HO-1, NQO-1, Keap1, and Sumo1 in each group of cells were detected by Western blotting. In addition, 2 μM TAK981 and 2 μM TAK981 combined with 10 μM ML385 (an Nrf2 inhibitor) were administered to HO-induced ARPE-19 cells, and the levels of SOD and MDA, IL-1β and TNF-αwere detected again.

Results

The viability of the ARPE-19 cells decreased with increasing HO concentration (=19.158, <0.001). HO treatment at 350 μM was the concentration at which the cells essentially reached half inhibition (IC50), and the cell oxidative damage model was successfully established. After intervention with TAK981, cell survival increased significantly (=0.098, <0.001). The differences between the 2 μM and 5 μM TAK981 groups and the model group were statistically significant (all <0.01). Compared with those in the normal group, the MDA content in the model group increased, the SOD activity decreased, and the release levels of IL-1β and TNF-α increased (all <0.01). Compared with those in the model group, the MDA content in the TAK981 group decreased, the SOD activity increased, and the release levels of IL-1β and TNF-α decreased. The differences between the 2 μM and 5 μM TAK981 groups were statistically significant (<0.05). Compared with those in the normal group, the protein expression levels of Nrf2, HO-1 and NQO-1 in the model group were greater, whereas the protein expression levels of Keap1 and Sumo1 were lower (all <0.05). Compared with those in the model group, the protein expression levels of Nrf2, HO-1 and NQO-1 in the TAK981-treated group continued to increase, whereas the protein expression levels of Keap1 and Sumo1 continued to decrease. The differences in the 5 μM TAK981 group were statistically significant (<0.05). In addition, after the combined intervention of TAK981 and ML385 on HO-induced cells, compared with the TAK981-only intervention on HO-induced cells, the cell viability increased, the MDA content increased, the SOD activity decreased, and the IL-1β and TNF-α release levels increased. The differences were statistically significant (<0.05).

Conclusion

The SUMOylation inhibitor TAK981 activates the Keap1/Nrf2/ARE signaling pathway, enhances the activity of antioxidant enzymes, and reduces the production of oxidative stress products and inflammatory factors, thereby exerting a protective effect on HO-induced oxidative damage in ARPE-19 cells. Therefore, it is suggested that intervention in SUMO regulation can be used as a new therapeutic target in the AMD disease model, in order to delay the development of AMD by reducing the oxidative damage of RPE.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cmm/10.2174/0115665240350793241214050904
2025-01-02
2025-12-31

  • From This Site

    /content/journals/cmm/10.2174/0115665240350793241214050904
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. YangY.K. Prevalence of age-related macular degeneration in a rural Chinese population: The handan eye study.Opthalmology202211871395140110.1016/j.ophtha.2010.12.230
     [Google Scholar]
  2. HanusJ. AndersonC. WangS. RPE necroptosis in response to oxidative stress and in AMD.Ageing Res. Rev.20152428629810.1016/j.arr.2015.09
     [Google Scholar]
  3. PandiS.S.P. RatnayakaJ.A. LoteryA. Progress in developing rodent models of age-related macular degeneration (AMD).Exp. Eye Res.202120310840410.1016/j.exer.2020.108404
     [Google Scholar]
  4. BlasiakJ. PetrovskiG. VerébZ. FacskóA. KaarnirantaK. Oxidative stress, hypoxia, and autophagy in the neovascular processes of age-related macular degeneration.BioMed Res. Int.201420141710.1155/2014/768026 24707498
     [Google Scholar]
  5. DattaS. CanoM. EbrahimiK. The impact of oxidative stress and inflammation on RPE degeneration in non-neovascular AMD.Prog. Retin. Eye Res.20176020121810.1016/j.preteyeres.2017.03.002
     [Google Scholar]
  6. ZhangL. LiD.W. SUMOylation regulation of retina development and functions.Curr. Mol. Med.201616980380810.2174/1566524016666161128115453 27894240
     [Google Scholar]
  7. LaBonneC. SUMO weighs in on a photoreceptor finish.Dev. Cell200916216516610.1016/j.devcel.2009.01.017 19217419
     [Google Scholar]
  8. PruddenJ. PebernardS. RaffaG. SUMO-targeted ubiquitin ligases in genome stability.EMBO J.200726184089410110.1038/sj.emboj.7601838 17762865
     [Google Scholar]
  9. MunM.J. KimJ.H. ChoiJ.Y. Polymorphisms of small ubiquitin-related modifier genes are associated with risk of Alzheimer’s disease in Korean: A case-control study.J. Neurol. Sci.201636412212710.1016/j.jns.2016.03.023 27084229
     [Google Scholar]
  10. HickeyC.M. WilsonN.R. HochstrasserM. Function and regulation of SUMO proteases.Nat. Rev. Mol. Cell Biol.2012131275576610.1038/nrm3478 23175280
     [Google Scholar]
  11. WangG. YangF. GaoT. WuD. HuangJ. LiJ. Effect of deletion of SUMOylation on dendritic cell function in septic mice and its role in sepsis.Zhong Nan Da Xue Xue Bao Yi Xue Ban202045331432110.11817/j.issn.1672‑7347.2020.190684 32386024
     [Google Scholar]
  12. SunQ. QingW. QiR. Inhibition of sumoylation alleviates oxidative stress-induced retinal pigment epithelial cell senescence and represses proinflammatory gene expression.Curr. Mol. Med.201918957558310.2174/1566524019666190107154250 30621561
     [Google Scholar]
  13. XiangJW Differential expression of the Sentrin/SUMO specific proteases (SENPs) in normal ocular tissues and mouse models of major ocular diseases2020
     [Google Scholar]
  14. WangP. WangX. QiaoK. Reduced SUMOylation of Nrf2 signaling contributes to its inhibition induced by amyloid-β.Neurosci. Lett.202379913711810.1016/j.neulet.2023.137118 36764479
     [Google Scholar]
  15. KomaravelliN. AnsarM. GarofaloR.P. CasolaA. Respiratory syncytial virus induces NRF2 degradation through a promyelocytic leukemia protein ‐ ring finger protein 4 dependent pathway.Free Radic. Biol. Med.201711349450410.1016/j.freeradbiomed.2017.10.380 29107745
     [Google Scholar]
  16. NieQ. GongX. GongL. Sodium iodate-induced mouse model of age-related macular degeneration displayed altered expression patterns of sumoylation enzymes E1, E2 and E3.Curr. Mol. Med.201918855055510.2174/1566524019666190112101147 30636606
     [Google Scholar]
  17. MaQ. Role of nrf2 in oxidative stress and toxicity.Annu. Rev. Pharmacol. Toxicol.201353140142610.1146/annurev‑pharmtox‑011112‑140320 23294312
     [Google Scholar]
  18. LiuS. PiJ. ZhangQ. Signal amplification in the KEAP1-NRF2-ARE antioxidant response pathway.Redox Biol.20225410238910.1016/j.redox.2022.102389
     [Google Scholar]
  19. HuangS. LiuC.H. WangZ. REV-ERBα regulates age-related and oxidative stress-induced degeneration in retinal pigment epithelium via NRF2.Redox Biol.20225110226110.1016/j.redox.2022.102261 35176707
     [Google Scholar]
  20. ZhaoZ. ChenY. WangJ. Age-related retinopathy in NRF2-deficient mice.Plos ONE201164e1945610.1371/journal.pone.0019456
     [Google Scholar]
  21. NitaM. GrzybowskiA. Antioxidative role of heterophagy, autophagy, and mitophagy in the retina and their association with the age-related macular degeneration (AMD) etiopathogenesis.Antioxidants2023127136810.3390/antiox12071368 37507908
     [Google Scholar]
  22. SahinU. FerhiO. JeanneM. Oxidative stress–induced assembly of PML nuclear bodies controls sumoylation of partner proteins.J. Cell Biol.2014204693194510.1083/jcb.201305148 24637324
     [Google Scholar]
  23. GómezJ.Y. MolinaA.D. BlancoB.M. Novel treatments for age-related macular degeneration: A review of clinical advances in sustained drug delivery systems.Pharmaceutics2022147147310.3390/pharmaceutics14071473 35890368
     [Google Scholar]
  24. BlasiakJ. PawlowskaE. SzczepanskaJ. Interplay between autophagy and the ubiquitin-proteasome system and its role in the pathogenesis of age-related macular degeneration.Int. J. Mol. Sci.201920121010.3390/ijms20010210
     [Google Scholar]
  25. MaX. LinW. LinZ. Liraglutide alleviates H 2 O 2 -induced retinal ganglion cells injury by inhibiting autophagy through mitochondrial pathways.Peptides2017921810.1016/j.peptides.2017.04.008 28450048
     [Google Scholar]
  26. LangstonS.P. GrossmanS. EnglandD. Discovery of TAK-981, a first-in-class inhibitor of sumo-activating enzyme for the treatment of cancer.J. Med. Chem.20216452501252010.1021/acs.jmedchem.0c01491 33631934
     [Google Scholar]
  27. LamV. RolederC. LiuT. T cell–intrinsic immuno-modulatory effects of TAK-981 (Subasumstat), a sumo-activating enzyme inhibitor, in chronic lymphocytic leukemia.Mol. Cancer Ther.20232291040105110.1158/1535‑7163.MCT‑22‑0762 37420267
     [Google Scholar]
  28. KumarS. SchoonderwoerdM.J.A. KroonenJ.S. Targeting pancreatic cancer by TAK-981: A SUMOylation inhibitor that activates the immune system and blocks cancer cell cycle progression in a preclinical model.Gut202271112266228310.1136/gutjnl‑2021‑324834 35074907
     [Google Scholar]
  29. YoussefA. MohammedB.K. PrasadA. Splenic SUMO1 controls systemic inflammation in experimental sepsis.Front. Immunol.202314120093910.3389/fimmu.2023.1200939 37520526
     [Google Scholar]
  30. NakamuraA. GrossmanS. SongK. The SUMOylation inhibitor subasumstat potentiates rituximab activity by IFN1-dependent macrophage and NK cell stimulation.Blood2022139182770278110.1182/blood.2021014267 35226739
     [Google Scholar]
  31. HuZ.L. LinZ-Y. RenW-S. Regulatory factors of Nrf2 in age-related macular degeneration pathogenesis.Int. J. Ophthalmol.20241771344136210.18240/ijo.2024.07.21 39026906
     [Google Scholar]
/content/journals/cmm/10.2174/0115665240350793241214050904
Loading
SUMOylation Inhibitors Exert a Protective Effect on Oxidative Damage in Retinal Pigment Epithelial Cells Through the Keap1/Nrf2/ARE Signaling Pathway
Current Molecular Medicine 25, 1181 (2025); https://doi.org/10.2174/0115665240350793241214050904
/content/journals/cmm/10.2174/0115665240350793241214050904
/content/journals/cmm/10.2174/0115665240350793241214050904
Loading

Data & Media loading...


  • Article Type:     Research Article
Keyword(s): Nrf2 signaling pathway; Oxidative stress; Retinal pigment epithelial cells; SUMOylation; TAK981

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test